Influence of solvent choice and operating conditions on Chlorzoxazone crystal shape and size

Detalhes bibliográficos
Autor(a) principal: Dhayananth Natarajan
Data de Publicação: 2023
Outros Autores: Kalaichelvi Ponnusamy, Radhakrishnan Thota Karunakaran, Karthika Shanmugam
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Pharmaceutical Sciences
Texto Completo: https://www.revistas.usp.br/bjps/article/view/211565
Resumo: Solubility of pharmaceutical drugs in organic solvents is one of the important parameters to understand the equilibrium concentration of solute-solvent, which helps optimize and design crystallization conditions to obtain the desired product crystals. In the present study, Chlorzoxazone (CHZ) is used as a model pharmaceutical compound to investigate the equilibrium solubility, the influence of solvent and the operating conditions on the shape, and the size distribution. The solubility of CHZ is determined in organic solvents like Isopropanol, Ethanol, and 2-Ethoxyethylacetate, Ethylacetate and Ethyllactate using shake flask method from -5ºC to 60ºC. The solubility of CHZ in these solvents shows an increasing trend as the temperature increases in the following order: ethyllactate + water (0.5+0.5) < ethylacetate < isopropanol < ethanol < 2-ethoxyethylacetate < ethyllactate + water (0.75+0.25). The solvents, isopropanol, ethanol, and ethyl lactate, produce needle-shaped crystals, while 2-ethoxyethylacetate and ethyl acetate tend to produce plate shaped crystals. CHZ crystals obtained from 2-ethoxyethylacetate tend to have plate shaped crystals with a lower aspect ratio and are selected for batch cooling crystallization experiments performed at different cooling rates, and agitation. It is found that the agitation at 300 rpm and the cooling rate 0.2ºC/min produce more uniform crystal size distribution.
id USP-31_a8cb31a0597075fd68b9720bd6df5162
oai_identifier_str oai:revistas.usp.br:article/211565
network_acronym_str USP-31
network_name_str Brazilian Journal of Pharmaceutical Sciences
repository_id_str
spelling Influence of solvent choice and operating conditions on Chlorzoxazone crystal shape and sizeChlorzoxazoneSolubilityCooling crystallizationSolvent choiceCrystal shapeSize distributionSolubility of pharmaceutical drugs in organic solvents is one of the important parameters to understand the equilibrium concentration of solute-solvent, which helps optimize and design crystallization conditions to obtain the desired product crystals. In the present study, Chlorzoxazone (CHZ) is used as a model pharmaceutical compound to investigate the equilibrium solubility, the influence of solvent and the operating conditions on the shape, and the size distribution. The solubility of CHZ is determined in organic solvents like Isopropanol, Ethanol, and 2-Ethoxyethylacetate, Ethylacetate and Ethyllactate using shake flask method from -5ºC to 60ºC. The solubility of CHZ in these solvents shows an increasing trend as the temperature increases in the following order: ethyllactate + water (0.5+0.5) < ethylacetate < isopropanol < ethanol < 2-ethoxyethylacetate < ethyllactate + water (0.75+0.25). The solvents, isopropanol, ethanol, and ethyl lactate, produce needle-shaped crystals, while 2-ethoxyethylacetate and ethyl acetate tend to produce plate shaped crystals. CHZ crystals obtained from 2-ethoxyethylacetate tend to have plate shaped crystals with a lower aspect ratio and are selected for batch cooling crystallization experiments performed at different cooling rates, and agitation. It is found that the agitation at 300 rpm and the cooling rate 0.2ºC/min produce more uniform crystal size distribution.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2023-04-28info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttps://www.revistas.usp.br/bjps/article/view/21156510.1590/s2175-97902023e20918Brazilian Journal of Pharmaceutical Sciences; Vol. 59 (2023); e20918Brazilian Journal of Pharmaceutical Sciences; v. 59 (2023); e20918Brazilian Journal of Pharmaceutical Sciences; Vol. 59 (2023); e209182175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/211565/194569https://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessDhayananth NatarajanKalaichelvi PonnusamyRadhakrishnan Thota KarunakaranKarthika Shanmugam2024-04-10T13:43:09Zoai:revistas.usp.br:article/211565Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2024-04-10T13:43:09Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Influence of solvent choice and operating conditions on Chlorzoxazone crystal shape and size
title Influence of solvent choice and operating conditions on Chlorzoxazone crystal shape and size
spellingShingle Influence of solvent choice and operating conditions on Chlorzoxazone crystal shape and size
Dhayananth Natarajan
Chlorzoxazone
Solubility
Cooling crystallization
Solvent choice
Crystal shape
Size distribution
title_short Influence of solvent choice and operating conditions on Chlorzoxazone crystal shape and size
title_full Influence of solvent choice and operating conditions on Chlorzoxazone crystal shape and size
title_fullStr Influence of solvent choice and operating conditions on Chlorzoxazone crystal shape and size
title_full_unstemmed Influence of solvent choice and operating conditions on Chlorzoxazone crystal shape and size
title_sort Influence of solvent choice and operating conditions on Chlorzoxazone crystal shape and size
author Dhayananth Natarajan
author_facet Dhayananth Natarajan
Kalaichelvi Ponnusamy
Radhakrishnan Thota Karunakaran
Karthika Shanmugam
author_role author
author2 Kalaichelvi Ponnusamy
Radhakrishnan Thota Karunakaran
Karthika Shanmugam
author2_role author
author
author
dc.contributor.author.fl_str_mv Dhayananth Natarajan
Kalaichelvi Ponnusamy
Radhakrishnan Thota Karunakaran
Karthika Shanmugam
dc.subject.por.fl_str_mv Chlorzoxazone
Solubility
Cooling crystallization
Solvent choice
Crystal shape
Size distribution
topic Chlorzoxazone
Solubility
Cooling crystallization
Solvent choice
Crystal shape
Size distribution
description Solubility of pharmaceutical drugs in organic solvents is one of the important parameters to understand the equilibrium concentration of solute-solvent, which helps optimize and design crystallization conditions to obtain the desired product crystals. In the present study, Chlorzoxazone (CHZ) is used as a model pharmaceutical compound to investigate the equilibrium solubility, the influence of solvent and the operating conditions on the shape, and the size distribution. The solubility of CHZ is determined in organic solvents like Isopropanol, Ethanol, and 2-Ethoxyethylacetate, Ethylacetate and Ethyllactate using shake flask method from -5ºC to 60ºC. The solubility of CHZ in these solvents shows an increasing trend as the temperature increases in the following order: ethyllactate + water (0.5+0.5) < ethylacetate < isopropanol < ethanol < 2-ethoxyethylacetate < ethyllactate + water (0.75+0.25). The solvents, isopropanol, ethanol, and ethyl lactate, produce needle-shaped crystals, while 2-ethoxyethylacetate and ethyl acetate tend to produce plate shaped crystals. CHZ crystals obtained from 2-ethoxyethylacetate tend to have plate shaped crystals with a lower aspect ratio and are selected for batch cooling crystallization experiments performed at different cooling rates, and agitation. It is found that the agitation at 300 rpm and the cooling rate 0.2ºC/min produce more uniform crystal size distribution.
publishDate 2023
dc.date.none.fl_str_mv 2023-04-28
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/bjps/article/view/211565
10.1590/s2175-97902023e20918
url https://www.revistas.usp.br/bjps/article/view/211565
identifier_str_mv 10.1590/s2175-97902023e20918
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/bjps/article/view/211565/194569
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
dc.source.none.fl_str_mv Brazilian Journal of Pharmaceutical Sciences; Vol. 59 (2023); e20918
Brazilian Journal of Pharmaceutical Sciences; v. 59 (2023); e20918
Brazilian Journal of Pharmaceutical Sciences; Vol. 59 (2023); e20918
2175-9790
1984-8250
reponame:Brazilian Journal of Pharmaceutical Sciences
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Brazilian Journal of Pharmaceutical Sciences
collection Brazilian Journal of Pharmaceutical Sciences
repository.name.fl_str_mv Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)
repository.mail.fl_str_mv bjps@usp.br||elizabeth.igne@gmail.com
_version_ 1800222918017286144